AnaptysBio shareholders approve amended equity plan, elect directors at 2025 annual meeting

ANAPTYSBIO, INC

Elected Rita Jain, John Orwin, and J. Anthony Ware as Class II directors for three-year terms with over 21M votes for each.
Approved amendment to 2017 Equity Incentive Plan with 18.0M for, 6.4M against; increases share reserve to 13.5M shares.
Ratified KPMG as independent auditor for FY2025 with 27.2M votes for, 17K against.
Advisory say-on-pay passed with 17.8M for, 6.6M against; shareholders preferred one-year frequency for future votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.